{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:23:54Z","timestamp":1793741034516,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573945"],"award-info":[{"award-number":["81573945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2021MH054"],"award-info":[{"award-number":["ZR2021MH054"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cbi.2024.111306","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T15:11:06Z","timestamp":1731424266000},"page":"111306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation"],"prefix":"10.1016","volume":"405","author":[{"given":"Guoliang","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111306_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111306_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2024.111306_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jconrel.2023.09.040","article-title":"Nonalcoholic fatty liver disease: current therapies and future perspectives in drug delivery","volume":"363","author":"Domingues","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.cbi.2024.111306_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2022.12.085","article-title":"Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells","volume":"195","author":"Yao","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2024.111306_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111306_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155630","article-title":"Protective effects of the succinate\/SUCNR1 axis on damaged hepatocytes in NAFLD","volume":"145","author":"Marsal-Beltran","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2024.111306_bib7","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.7150\/ijbs.73890","article-title":"Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease","volume":"18","author":"Fan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2024.111306_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111306_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154326","article-title":"Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease","volume":"104","author":"Jia","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111306_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155183","article-title":"Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1","volume":"123","author":"Shang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111306_bib11","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.2147\/DMSO.S326054","article-title":"The effects of diosgenin on hypolipidemia and its underlying mechanism: a review","volume":"14","author":"Sun","year":"2021","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.cbi.2024.111306_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111306_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154661","article-title":"Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake","volume":"111","author":"Nie","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111306_bib14","first-page":"1","article-title":"Diosgenin ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and related lipid\/amino acid metabolism in high fat diet-fed rats","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111306_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175808","article-title":"Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C\/PPAR\u03b1\/CD36 pathway","volume":"952","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111306_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbalip.2019.04.010","article-title":"Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8","volume":"1864","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2024.111306_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111306_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.apsb.2022.10.003","article-title":"Synergistic activation of AMPK by AdipoR1\/2 agonist and inhibitor of EDPs\u2013EBP interaction recover NAFLD through enhancing mitochondrial function in mice","volume":"13","author":"Song","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2024.111306_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.10.042","article-title":"Pharmacologic inhibition of lipogenesis for the treatment of NAFLD","volume":"80","author":"Esler","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111306_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0041-1729971","article-title":"Dietary treatment for NAFLD: new clinical and epidemiological evidence and updated recommendations","volume":"41","author":"Zelber-Sagi","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cbi.2024.111306_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cbi.2024.111306_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115769","article-title":"Exploring the active compounds and potential mechanism of the anti-nonalcoholic fatty liver disease activity of the fraction from Schisandra chinensis fruit extract based on multi-technology integrated network pharmacology","volume":"301","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2024.111306_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154798","article-title":"Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway","volume":"114","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111306_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/biof.1815","article-title":"Dioscin: a review on pharmacological properties and therapeutic values","volume":"48","author":"Bandopadhyay","year":"2022","journal-title":"Biofactors"},{"key":"10.1016\/j.cbi.2024.111306_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.phrs.2018.09.022","article-title":"Dioscin: a diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections","volume":"137","author":"Tao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111306_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.03.017","article-title":"Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1\/AMPK signaling pathway","volume":"131","author":"Yao","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111306_bib27","article-title":"Potent effects of dioscin against obesity in mice","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111306_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112581","article-title":"Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway","volume":"138","author":"Yu","year":"2024","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.111306_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2024.111306_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050626","article-title":"Novel selective PPAR\u03b1 modulator pemafibrate for dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and atherosclerosis","volume":"13","author":"Yamashita","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.cbi.2024.111306_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cbi.2024.111306_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101462","article-title":"Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-\u03baB signaling pathway","volume":"59","author":"Jiang","year":"2022","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.cbi.2024.111306_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100412","article-title":"Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD","volume":"4","author":"van der Graaff","year":"2022","journal-title":"JHEP Reports"},{"key":"10.1016\/j.cbi.2024.111306_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2024.111306_bib35","doi-asserted-by":"crossref","first-page":"20105","DOI":"10.1021\/acs.jafc.3c06498","article-title":"Nobiletin ameliorates hepatic lipid deposition, oxidative stress, and inflammation by mechanisms that involve the Nrf2\/NF-\u03baB Axis in nonalcoholic fatty liver disease","volume":"71","author":"Fan","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cbi.2024.111306_bib36","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/15548627.2022.2037853","article-title":"MTOR-mediates hepatic lipid metabolism through an autophagic SNARE complex","volume":"18","author":"Ouyang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111306_bib37","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.2147\/DMSO.S380053","article-title":"Follistatin alleviates hepatic steatosis in NAFLD via the mTOR dependent pathway","volume":"15","author":"Tong","year":"2022","journal-title":"Diabetes, Metab. Syndr. Obes."},{"key":"10.1016\/j.cbi.2024.111306_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174857","article-title":"mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis","volume":"921","author":"Arora","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111306_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2112040119","article-title":"FASN-dependent de novo lipogenesis is required for brain development","volume":"119","author":"Gonzalez-Bohorquez","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2024.111306_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu13072331","article-title":"\u03b1-Lipoic acid alleviates hepatic lipid deposition by inhibiting FASN expression via miR-3548 in rats","volume":"13","author":"Guo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2024.111306_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115768","article-title":"Sesamin ameliorates lipotoxicity and lipid accumulation through the activation of the estrogen receptor alpha signaling pathway","volume":"216","author":"Pham","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111306_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102603","article-title":"Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1\u03b1 and NRF2 as therapeutic targets","volume":"60","author":"Bourgonje","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2024.111306_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2023.07.036","article-title":"Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT\/mTOR\/HIF-1\u03b1 pathway","volume":"208","author":"Wang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2024.111306_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through hif-1 and nf-\u03bab activation. A review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111306_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.cbi.2024.111306_bib46","article-title":"Dapagliflozin-loaded exosome mimetics facilitate diabetic wound healing by HIF-1\u03b1-Mediated enhancement of angiogenesis","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.cbi.2024.111306_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111306_bib48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopha.2018.05.102","article-title":"Targeted therapy of chronic liver diseases with the inhibitors of angiogenesis","volume":"105","author":"Srivastava","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111306_bib49","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.actbio.2022.08.054","article-title":"An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1\u03b1\/NF-\u03baB cascade regulation of ROS scavenging and macrophage repolarization","volume":"152","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.cbi.2024.111306_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01367-5","article-title":"Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells","volume":"3","author":"Seo","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cbi.2024.111306_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7150\/ijbs.77304","article-title":"TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury","volume":"19","author":"Zhong","year":"2023","journal-title":"Int. J. Biol. Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T12:11:41Z","timestamp":1733659901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724004526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0009279724004526"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111306","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111306"}}